6660 — AIM Vaccine Co Cashflow Statement
0.000.00%
- HK$3.98bn
- HK$5.57bn
- CNY1.29bn
Annual cashflow statement for AIM Vaccine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 486 | -607 | -434 | -2,271 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 30.6 | 973 | 294 | 1,813 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -395 | -417 | -136 | 111 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 250 | 93.4 | -110 | -165 | — |
Capital Expenditures | -667 | -1,142 | -857 | -302 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 62.1 | -196 | -1.51 | 29.7 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -605 | -1,338 | -858 | -272 | — |
Financing Cash Flow Items | 744 | -42.2 | -10.8 | -48.2 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1,139 | 788 | 980 | 362 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 784 | -456 | 9.53 | -73.1 | — |